EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway [Retraction]
Zhang R, Han D, Li L, Luo W, Liu J, Qian L. Cancer Manag Res. 2020;12:9539—9549. We, the Editors and Publisher of the journal Cancer Management and Research have retracted the published article. After publication, concerns have been raised by a third party about the integrity of the...
Saved in:
| Main Authors: | Zhang R, Han D, Li L, Luo W, Liu J, Qian L |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/retraction-epha5-silencing-increases-the-radiosensitivity-of-escc-cell-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis
by: Eun Hye Lee, et al.
Published: (2025-01-01) -
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
by: Lidia Moyano‐Galceran, et al.
Published: (2020-03-01) -
EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK
by: Nozomi Hirai, et al.
Published: (2025-05-01) -
Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
by: Huangde Fu, et al.
Published: (2025-02-01) -
Targeting EphA2 suppresses the proliferation, migration and invasion of endometriosis via the AMPK signaling pathway
by: Chaoyi Yang, et al.
Published: (2025-06-01)